E-LIB Suche - Ergebnisse für: De la Fouchardière, Christelle

1

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease. 56 (2024) 8 - p. 1281-1287 , 2024

Link: https://doi.org/10.1016/..

2

Biliary tract cancers: French national clinical practice gu..:

Roth, Gael S. ; Verlingue, Loic ; Sarabi, Matthieu...
European Journal of Cancer. 202 (2024) - p. 114000 , 2024

Link: https://doi.org/10.1016/..

3

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology. 25 (2024) 4 - p. 518-528 , 2024

Link: https://doi.org/10.1016/..

4

Sunitinib for metastatic progressive phaeochromocytomas and..:

Baudin, Eric ; Goichot, Bernard ; Berruti, Alfredo...
The Lancet. 403 (2024) 10431 - p. 1061-1070 , 2024

Link: https://doi.org/10.1016/..

5

Triplet chemotherapy plus cetuximab as first-line treatment..:

Samalin, Emmanuelle ; Mazard, Thibault ; Assenat, Eric...
Digestive and Liver Disease. 56 (2024) 8 - p. 1375-1381 , 2024

Link: https://doi.org/10.1016/..

6

A multicenter study evaluating efficacy of immune checkpoin..:

Moreau, Mathilde ; Alouani, Emily ; Flecchia, Clémence...
European Journal of Cancer. 202 (2024) - p. 114033 , 2024

Link: https://doi.org/10.1016/..

7

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Current picture of anaplastic thyroid cancer patients' care..:

Locati, Laura D. ; Colombo, Elena ; Dedecjus, Marek...
European Journal of Cancer. 180 (2023) - p. 146-154 , 2023

Link: https://doi.org/10.1016/..

9

Improved guidance is needed to optimise diagnostics and tre..:

de la Fouchardière, Christelle ; Fugazzola, Laura ; Locati, Laura D....
Endocrine. 83 (2023) 3 - p. 585-593 , 2023

Link: https://doi.org/10.1007/..

10

BRAFV600E Metastatic Colorectal Cancer: Perspective from a ..:

Gourdin, Guillaume ; Chotel, Laure ; de la Fouchardière, Christelle
Advances in Therapy. 40 (2023) 8 - p. 3281-3290 , 2023

Link: https://doi.org/10.1007/..

11

Prognostic value of Lynch syndrome, BRAFV600E, and RAS muta..:

Zwart, Koen ; van der Baan, Frederieke H. ; Cohen, Romain...
Cancer Medicine. 12 (2023) 15 - p. 15841-15853 , 2023

Link: https://doi.org/10.1002/..

12

Pathogenic alterations in PIK3CA and KMT2C are frequent and..:

Hamza, Abderaouf ; Masliah‐Planchon, Julien ; Neuzillet, Cindy...
International Journal of Cancer. 154 (2023) 3 - p. 504-515 , 2023

Link: https://doi.org/10.1002/..

13

Complete pathological response after chemotherapy or immune..:

Marolleau, Pauline ; Tougeron, David ; Allignet, Benoit...
International Journal of Cancer. 153 (2023) 7 - p. 1376-1385 , 2023

Link: https://doi.org/10.1002/..

14

Sorafenib in Molecularly Selected Cancer Patients: Final An..:

Trédan, Olivier ; Toulmonde, Maud ; Le Tourneau, Christophe...
Cancers. 15 (2023) 13 - p. 3441 , 2023

Link: https://doi.org/10.3390/..

15

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatmen..:

Wainberg, Zev A ; Melisi, Davide ; Macarulla, Teresa...
The Lancet. 402 (2023) 10409 - p. 1272-1281 , 2023

Link: https://doi.org/10.1016/..